These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Long-term outcomes and recurrence patterns in upper gastrointestinal tract gastrointestinal stromal tumours (GISTs) treated by minimally invasive surgery. Photi ES, Igali L, Cheong EC, Clark A, Lewis MP. Dig Surg; 2014; 31(3):185-9. PubMed ID: 25095752 [Abstract] [Full Text] [Related]
5. Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome. Cavnar MJ, Wang L, Balachandran VP, Antonescu CR, Tap WD, Keohan M, Singer S, Temple L, Nash GM, Weiser MR, Guillem JG, Aguilar JG, DeMatteo RP, Paty PB. Ann Surg Oncol; 2017 Dec; 24(13):3972-3980. PubMed ID: 29058144 [Abstract] [Full Text] [Related]
6. Gastrointestinal Stromal Tumours of the Rectum - Evaluating the National Registry Data with Respect to its Use in Clinical Practice. Svatoň R, Kala Z, Kysela P, Procházka V, Eid M, Andrašina T, Poredská K, Strenková J, Chloupková R, Kunovsky L. Klin Onkol; 2019 Dec; 32(2):117-123. PubMed ID: 30995851 [Abstract] [Full Text] [Related]
7. Surgical management of gastrointestinal stromal tumours: a single centre experience during the past 17 years. De Vogelaere K, Van De Winkel N, Aerts M, Haentjens P, Spitali C, Van Loo I, Delvaux G. Acta Chir Belg; 2014 Dec; 114(3):167-73. PubMed ID: 25102705 [Abstract] [Full Text] [Related]
9. Efficacy of Long-Term Adjuvant Therapy With Imatinib Mesylate After Extensive Surgical Treatment for Ruptured Gastrointestinal Stromal Tumors of the Small Intestine With Peritoneal Metastases: A Case Report. Kimura T, Togawa T, Onishi K, Iida A, Sato Y, Goi T. J Investig Med High Impact Case Rep; 2020 Dec; 8():2324709620970736. PubMed ID: 33228387 [Abstract] [Full Text] [Related]
14. Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience. Kim JH, Ryu MH, Yoo C, Chae H, Na H, Beck M, Kim BS, Yoo MW, Yook JH, Kim BS, Kim KH, Kim CW, Kang YK. Cancer Med; 2019 Mar; 8(3):1034-1043. PubMed ID: 30693663 [Abstract] [Full Text] [Related]
15. Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial. Raut CP, Espat NJ, Maki RG, Araujo DM, Trent J, Williams TF, Purkayastha DD, DeMatteo RP. JAMA Oncol; 2018 Dec 01; 4(12):e184060. PubMed ID: 30383140 [Abstract] [Full Text] [Related]
19. Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European study. Mohammadi M, IJzerman NS, Hohenberger P, Rutkowski P, Jones RL, Martin-Broto J, Gronchi A, Schöffski P, Vassos N, Farag S, Baia M, Oosten AW, Steeghs N, Desar IME, Reyners AKL, van Sandick JW, Bastiaannet E, Gelderblom H, Schrage Y. Eur J Surg Oncol; 2021 Aug 01; 47(8):2173-2181. PubMed ID: 33895019 [Abstract] [Full Text] [Related]